|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
138,140,000 |
Market
Cap: |
142.28(M) |
Last
Volume: |
3,241,097 |
Avg
Vol: |
3,337,696 |
52
Week Range: |
$1.03 - $1.03 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
50,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
0 |
0 |
460,129 |
Total Sell Value |
$0 |
$0 |
$0 |
$318,958 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
13 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Vacirca Jeff L |
Director |
|
2023-07-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(295,244) |
0 |
|
- |
|
Riga Thomas J |
See Remarks |
|
2023-07-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,839,639) |
0 |
|
- |
|
Lim Juhyun |
Director |
|
2023-07-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(29,759) |
0 |
|
- |
|
Brennan Nora |
See Remarks |
|
2023-07-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(567,828) |
0 |
|
- |
|
Mcgahan Keith M |
See Remarks |
|
2023-07-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(618,312) |
0 |
|
- |
|
Ashton William |
Director |
|
2023-07-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(67,660) |
0 |
|
- |
|
Bradrick Brittany |
Director |
|
2023-07-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(27,380) |
0 |
|
- |
|
Fischer Seth H.z. |
Director |
|
2023-07-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,066) |
0 |
|
- |
|
Brennan Nora |
CFO |
|
2023-05-26 |
4 |
AS |
$1.10 |
$35,496 |
D/D |
(32,387) |
567,828 |
|
-7% |
|
Riga Thomas J |
CEO & President |
|
2023-03-15 |
4 |
AS |
$0.80 |
$24,979 |
D/D |
(31,381) |
472,411 |
|
26% |
|
Mcgahan Keith M |
Chief Legal Officer |
|
2023-03-15 |
4 |
AS |
$0.80 |
$21,649 |
D/D |
(27,197) |
189,325 |
|
26% |
|
Riga Thomas J |
CEO & President |
|
2023-03-14 |
4 |
AS |
$0.82 |
$14,867 |
D/D |
(18,153) |
503,792 |
|
24% |
|
Mcgahan Keith M |
Chief Legal Officer |
|
2023-03-14 |
4 |
AS |
$0.82 |
$12,885 |
D/D |
(15,733) |
216,522 |
|
24% |
|
Mcgahan Keith M |
Chief Legal Officer |
|
2023-02-23 |
4 |
AS |
$0.77 |
$14,156 |
D/D |
(18,385) |
618,312 |
|
19% |
|
Mcgahan Keith M |
Chief Legal Officer |
|
2023-02-22 |
4 |
AS |
$0.76 |
$9,124 |
D/D |
(11,990) |
636,697 |
|
26% |
|
Riga Thomas J |
CEO & President |
|
2023-02-22 |
4 |
AS |
$0.76 |
$28,365 |
D/D |
(37,009) |
1,839,639 |
|
26% |
|
Mcgahan Keith M |
Chief Legal Officer |
|
2023-01-31 |
4 |
AS |
$0.62 |
$25,429 |
D/D |
(41,014) |
645,873 |
|
46% |
|
Riga Thomas J |
CEO & President |
|
2023-01-31 |
4 |
AS |
$0.66 |
$70,900 |
D/D |
(107,424) |
1,900,598 |
|
46% |
|
Mcgahan Keith M |
Chief Legal Officer |
|
2023-01-30 |
4 |
AS |
$0.54 |
$14,219 |
D/D |
(26,138) |
686,887 |
|
94% |
|
Riga Thomas J |
CEO & President |
|
2023-01-30 |
4 |
AS |
$0.54 |
$37,748 |
D/D |
(69,389) |
2,008,022 |
|
94% |
|
Mcgahan Keith M |
Chief Legal Officer |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
222,000 |
713,025 |
|
- |
|
Riga Thomas J |
CEO & President |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
888,000 |
2,077,411 |
|
- |
|
Riga Thomas J |
CEO & President |
|
2023-01-03 |
4 |
AS |
$0.38 |
$9,141 |
D/D |
(23,929) |
1,189,411 |
|
240% |
|
Brennan Nora |
See Remarks |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
240,000 |
600,215 |
|
- |
|
Vacirca Jeff L |
Director |
|
2022-11-30 |
4 |
B |
$0.45 |
$22,500 |
D/D |
50,000 |
270,244 |
2.39 |
41% |
|
467 Records found
|
|
Page 1 of 19 |
|
|